Rgenta Therapeutics, Inc

Azurity Pharmaceuticals is a leading pharmaceutical company based in Woburn, MA, specializing in the development and production of a wide range of healthcare solutions. With a diverse portfolio of products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, endocrinology, gastrointestinal, oncology, and more, Azurity Pharmaceuticals is committed to providing innovative and effective treatments for patients. Their dedication to quality and patient support is evident in their comprehensive range of services, including medical information, patient support programs, and compounding kits. With multiple campuses across the United States, including their corporate headquarters in Boston, manufacturing operations in Wilmington, and research and development campuses in Atlanta and Kansas City, Azurity Pharmaceuticals is well-positioned to meet the needs of patients and healthcare professionals nationwide. Their commitment to excellence and their focus on delivering high-quality pharmaceutical products make them a trusted name in the industry.Generated from the website

ImmunoMolecular Therapeutics, Inc., based in Woburn, MA, is pioneering the development of novel personalized medicines aimed at treating autoimmune diseases through a targeted drug design approach. The company is focused on building an HLA-directed platform for new therapies, demonstrating early effectiveness in conditions such as type 1 diabetes while expanding its pipeline across various autoimmune disorders. Utilizing innovative therapies that specifically block the action of HLA proteins involved in triggering autoimmune responses, ImmunoMolecular Therapeutics is committed to transforming lives through its patient-centered approach. The company has garnered attention for its promising early results in clinical trials and for its leadership in the field of autoimmune disease therapeutics. Generated from the website

ChemGenes Corporation, a biotechnology company, recently relocated to a state of the art facility in Wilmington, Massachusetts. We have consistently been a strong partner to researchers engaged in the field of DNA/RNA synthesis for 23 years. By starting out as a supplier of 'Ultra Pure Products' and then also by becoming an active Contract Researcher, ChemGenes Corporation has achieved unparalleled expertise in the field of DNA/RNA synthesis. Thus, all of us at ChemGenes have the opportunity and great pleasure to serve a vast number of scientists in the US and all over the world.ChemGenes' product lines include phosphoramidites for RNA and DNA synthesis, Antisense phosphoramidites, modified bases for DNA, as well as RNA modification. In addition, we produce a variety of modified phosphoramidites for the introduction of chromophores and ligands. The availability of prepacked disposable columns of various pore sizes, loadings, low volume columns, ancillary reagents in configurations suitable for each synthesizer, and DNA purification cartridges is another way ChemGenes meets its customers needs.A large variety of Reagents for the synthesis of DNA/RNA are also available, which include many natural and modified nucleoside bases, tetrazole, 5-thioethyltetrazole, DMT-chloride, DMT protected deoxy and ribo nucleosides, 2'-O-methyl and 2'-O-propargyl nucleosides, silyl protected ribonucleosides, several types of phosphorylating reagents, and many more.